Reporting Manager
Boothbay Fund Management, LLC
Symbol
FBRX
Shares outstanding
1,479,750 shares
Disclosed Ownership
88,785 shares
Ownership
6%
Form type
SCHEDULE 13G
Filing time
13 Feb 2025, 11:20:49 UTC
Date of event
31 Dec 2024
Next filing
07 Aug 2025

Sponsored

Quoteable Key Fact

"BOOTHBAY FUND MANAGEMENT, LLC disclosed 6% ownership in Forte Biosciences, Inc. Common Stock, $0.001 par value per share (FBRX) on 31 Dec 2024."

Quick Takeaways

  • BOOTHBAY FUND MANAGEMENT, LLC filed SCHEDULE 13G for Forte Biosciences, Inc. Common Stock, $0.001 par value per share (FBRX).
  • Disclosed ownership: 6%.
  • Date of event: 31 Dec 2024.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 13 Feb 2025, 11:20.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Boothbay Fund Management, LLC 6% 88,785 0 88,785 /s/ Ari Glass Ari Glass, Managing Member
Ari Glass 6% 88,785 0 88,785 /s/ Ari Glass Individually